Palivizumab | 188039-54-5 - MedChemExpress
2023-02-24 15:34 作者:bili_92778524386 | 我要投稿
MCE 的所有產(chǎn)品僅用作科學(xué)研究或藥證申報(bào),我們不為任何個(gè)人用途提供產(chǎn)品和服務(wù)。
Palivizumab
品牌:MedChemExpress (MCE)
Drug_Names:Palivizumab
CAS:188039-54-5
產(chǎn)品活性:Palivizumab (MEDI 493) 是一種人源化呼吸道合胞病毒單克隆抗體,可減少呼吸道合胞病毒感染 (RSV)[1]。
存儲(chǔ)條件:Please store the product under the recommended conditions in the Certificate of Analysis.
參考文獻(xiàn):
Palivizumab, a humanized respiratory syncytial virus monoclonal antibody, reduces hospitalization from respiratory syncytial virus infection in high-risk infants. The IMpact-RSV Study Group. Pediatrics. 1998 Sep;102(3 Pt 1):531-7.
標(biāo)簽: